| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |